Peripheral Neuropathy Trial, Recruiting (NCT05639478)

Peripheral Neuropathy Trial, Recruiting NCT05639478 Sponsor: University of Sao Paulo General Hospital Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT05639478 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be an adult (any gender)
You have been diagnosed with type 1 or type 2 diabetes
You live within the local area served by the Family Health Units in the study
You are available to attend group sessions at the scheduled times

Who may not be able to join:

You have been diagnosed with dementia
You are unable to provide reliable and consistent information (confirm with trial site)
You are already receiving physiotherapy treatment during the period the trial takes place
You currently have an active foot ulcer or serious blood vessel complications related to diabetes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Isabel CN Sacco, PhD, Associate Professor at Medicine of University of São Paulo

Phone: +551130918426

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05639478

Sponsor: University of Sao Paulo General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +551130918426

More information: https://clinicaltrials.gov/study/NCT05639478

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be an adult (any gender)
You have been diagnosed with type 1 or type 2 diabetes
You live within the local area served by the Family Health Units in the study
You are available to attend group sessions at the scheduled times

Who may not be able to join:

You have been diagnosed with dementia
You are unable to provide reliable and consistent information (confirm with trial site)
You are already receiving physiotherapy treatment during the period the trial takes place
You currently have an active foot ulcer or serious blood vessel complications related to diabetes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo General Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2023

Est. completion

30 June 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change From Baseline Diabetic Neuropathy Symptoms at 12-week Instrument; Change From Baseline of the Foot and Ankle range of motion at 12-week

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov